Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

During the Trading Day
1.22 +0.07 / +6.09%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
1.22 0.00 / 0.00%
Volume: 5.0K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Quarter 4
Quarter 1
Quarter 2
Quarter 3
Revenue and IncomeNet Revenues6.3M5.7M9.3M9.7M
Cost of Goods Sold3.9M2.9M4.5M4.4M
Depreciation And Amortization265.0K261.0K238.0K234.0K
Operating ExpensesGross Income2.2M2.6M4.6M5.1M
General Expenses14.3M15.6M16.7M18.8M
Research And Development10.0M11.3M11.5M13.9M
Total Operating Expenses18.4M18.7M21.5M23.4M
Non-Operating ExpensesOperating Income-12.1M-13.0M-12.2M-13.8M
Interest Expense On Debt0.001.0K0.000.00
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-12.1M-13.0M-12.1M-13.7M
Preferred Dividend-1.0M-1.0M-1.4M-1.4M
Net Income-12.1M-13.0M-12.1M-13.7M
Shares To Calculate EPSShares To Calculate EPS180.0M182.5M188.7M197.3M
Shares To Calculate EPS Diluted180.0M182.5M188.7M197.3M
Earnings Per ShareEPS-$0.07-$0.08-$0.07-$0.08
EPS Diluted-$0.07-$0.08-$0.07-$0.08